Related Experiment Videos

Toxic proteins from European mistletoe (Viscum album L.): increase of intracellular IL-4 but decrease of IFN-gamma in

G M Stein1, U Pfüller, M Schietzel

  • 1Krebsforschung Herdecke, Department of Applied Immunology, University Witten/Herdecke, Communal Hospital, Germany. stein.g@debitel.net

Anticancer Research
|August 6, 2000
PubMed
Abstract

Insights

Mistletoe lectins (ML) induce apoptosis and increase Interleukin-4 (IL-4) in T-cells, primarily in dying cells. This suggests IL-4 plays a role in apoptosis beyond T-helper cell activation.

Area of Science:

  • Immunology
  • Cancer Therapy

Background:

  • Mistletoe lectins (ML) are key components of mistletoe extracts used in cancer therapy.
  • ML induce apoptosis in lymphocytes and tumor cells.
  • The role of dying versus activated cells in cytokine release upon ML exposure is unclear.

Purpose of the Study:

  • To investigate the role of ML and viscotoxins (VT) in cytokine production and apoptosis.
  • To determine if IL-4 expression is linked to apoptosis or necrosis induced by ML.

Main Methods:

  • Flow cytometry was used to analyze IFN-gamma, IL-4, Apo2.7 (apoptosis marker), and Bcl-2 protein expression.
  • Peripheral blood mononuclear cells (PBMC) from controls and plasmocytoma cells (U-266) were treated with ML or VT.

Main Results:

  • ML inhibited IFN-gamma production but increased IL-4 expression in CD8+ and CD4+ T-cells.
  • IL-4 was predominantly found in apoptotic cells with low Bcl-2 levels.
  • VT induced cell membrane permeabilization and Bcl-2 loss but not IL-4 production, indicating IL-4 is linked to apoptosis, not necrosis.

Conclusions:

  • IL-4 expression is associated with apoptosis induced by mistletoe lectins.
  • IL-4 may have an important, yet undefined, role in the apoptosis of normal and tumor cells.
  • These findings contribute to understanding the mechanisms of mistletoe extract in cancer therapy.

Related Concept Videos